Cellosaurus MYCN-3 Tet-on (CVCL_VL19)
| Cell line name | MYCN-3 Tet-on |
|---|---|
| Synonyms | MYCN-3 |
| Accession | CVCL_VL19 |
| Resource Identification Initiative | To cite this cell line use: MYCN-3 Tet-on (RRID:CVCL_VL19) |
| Comments | Population: Caucasian. Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16. Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7559; MYCN. Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR. Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del). Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371. |
| Sequence variations |
|
| Disease | Neuroblastoma (NCIt: C3270) Neuroblastoma (ORDO: Orphanet_635) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_0524 (SH-EP) |
| Sex of cell | Female |
| Age at sampling | 4Y |
| Category | Cancer cell line |
| Publications | PubMed=15644444; DOI=10.1073/pnas.0405495102; PMCID=PMC545522 |
| Cross-references | |
| Cell line databases/resources | cancercelllines; CVCL_VL19 |
| Encyclopedic resources | Wikidata; Q95991617 |
| Entry history | |
| Entry creation | 07-Sep-2018 |
| Last entry update | 14-Aug-2025 |
| Version number | 11 |